| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Heart (Atrial fibrillation)Heart (Atrial flutter)DefibrillationHeart (Echocardiography)Heart (Arrhythmia)Electrophysiological examination of the heartPropafenoneAnticoagulantsDabigatranCardiac pacemaker (biventricular)ElectrocardiographyRanolazineClopidogrelDronedaroneStroke (BASKET)Heart (CT)StatinCardiovascular riskHolt Oram s syndromeConnexin40D DimersCoronary heart disease (BASKET)FlecainideHeart (MRT)Wolff Parkinson White syndromeAntitachycardia pacingThyroid (Thyreotoxicosis)Heart (Atrial septum defect)| 1 | 2005 | Recent developments in atrial fibrillation. | 
| + | - | nl | BMJ 330(7485):238-43 (2005) |
| 2 | 1996 | ABC of atrial fibrillation. Atrial fibrillation in general and hospital practice. | 
| + | - | nl | BMJ 312(7024):175-8 (1996) |
| 3 | 1996 | ABC of atrial fibrillation. Cardioversion of atrial fibrillation. | 
| + | - | nl | BMJ 312(7023):112-5 (1996) |
| 4 | 1996 | ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation. | 
| + | - | nl | BMJ 312(7022):45-9 (1996) |
| 5 | 1995 | ABC of atrial fibrillation. Drugs for atrial fibrillation. | 
| + | - | nl | BMJ 311(7020):1631-4 (1995) |
| 6 | 1995 | ABC of atrial fibrillation. Investigation and non-drug management of atrial fibrillation. | 
| + | - | nl | BMJ 311(7019):1562-5 (1995) |
| 7 | 1995 | ABC of atrial fibrillation. Differential diagnosis of atrial fibrillation. | 
| + | - | nl | BMJ 311(7018):1495-8 (1995) |
| 8 | 1995 | ABC of atrial fibrillation. Aetiology, pathophysiology, and clinical features. | 
| + | - | nl | BMJ 311(7017):1425-8 (1995) |
| 9 | 1995 | ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. | 
| + | - | nl | BMJ 311(7016):1361-3 (1995) |
| 10 | 1999 | Practical management of atrial fibrillation. | 
| + | - | nl | South Med J 92(12):1136-43 (1999) |
| 11 | 1996 | Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. | 
| + | - | nl | South Med J 89(8):779-85 (1996) |
| 12 | 2008 | The impact of statin use on atrial fibrillation. | 
| + | - | nl | QJM 101(11):845-61 (2008) |
| 13 | 2003 | Rate or rhythm control in persistent atrial fibrillation? | 
| + | - | nl | QJM 96(12):881-92 (2003) |
| 14 | 2001 | Paroxysmal atrial fibrillation. | 
| + | - | nl | QJM 94(12):665-78 (2001) |
| 15 | 2000 | Atrial electrical remodelling and atrial fibrillation. | 
| + | - | nl | QJM 93(9):563-5 (2000) |
| 16 | 2010 | Contemporary management of atrial fibrillation: a brief review. | 
| + | - | nl | Adv Med Sci 55(2):130-6 (2010) |
| 17 | 2007 | Atrial fibrillation. | 
| + | - | nl | Med J Aust 186(4):197-202 (2007) |
| 18 | 2008 | Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. | 
| + | - | nl | Arch Intern Med 168(6):581-6 (2008) |
| 19 | 2006 | Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. | 
| + | - | nl | Arch Intern Med 166(7):719-28 (2006) |
| 20 | 2005 | Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. | 
| + | - | nl | Arch Intern Med 165(3):258-62 (2005) |
| 21 | 2003 | Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. | 
| + | - | nl | Arch Intern Med 163(7):777-85 (2003) |
| 22 | 2002 | Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation. | 
| + | - | nl | Arch Intern Med 162(5):541-50 (2002) |
| 23 | 2007 | Atrial fibrillation: insights from clinical trials and novel treatment options. | 
| + | - | nl | J Intern Med 262(6):593-614 (2007) |
| 24 | 2005 | Paroxysmal atrial fibrillation: why patients experience different symptoms from the same arrhythmia? | 
| + | - | nl | Neth J Med 63(5):154-5 (2005) |
| 25 | 2009 | Ablation of atrial fibrillation: what can we tell our patients? | 
| + | - | nl | Cleve Clin J Med 76(9):543-50 (2009) Chowdhury P |
| 26 | 2009 | Should catheter ablation be the first line of treatment for atrial fibrillation? | 
| + | - | nl | Cleve Clin J Med 76(9):503, 506 (2009) |
| 27 | 2003 | Managing chronic atrial fibrillation: strategies to control symptoms and prevent embolism. | 
| + | - | nl | Cleve Clin J Med 70 Suppl 3(-):S30-3 (2003) |
| 28 | 2003 | Approaches to restoring and maintaining normal sinus rhythm. | 
| + | - | nl | Cleve Clin J Med 70 Suppl 3(-):S12-29 (2003) |
| 29 | 2003 | Current clinical issues in atrial fibrillation. | 
| + | - | nl | Cleve Clin J Med 70 Suppl 3(-):S6-11 (2003) |
| 30 | 2003 | Basic mechanisms of atrial fibrillation. | 
| + | - | nl | Cleve Clin J Med 70 Suppl 3(-):S2-5 (2003) |
| 31 | 2007 | Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical framework. | 
| + | - | nl | Crit Care 11(6):233 (2007) |
| 32 | 2004 | Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control. | 
| + | - | nl | Crit Care 8(4):271-9 (2004) |
| 33 | 2010 | Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter. | 
| + | - | nl | Acad Emerg Med 17(4):408-15 (2010) |
| 34 | 2005 | Best evidence topic report. Anticoagulation before cardioversion of acute atrial fibrillation in the emergency department. | 
| + | - | nl | Emerg Med J 22(4):275 (2005) |
| 35 | 2005 | Best evidence topic report. Anticoagulation post-cardioversion of acute atrial fibrillation in the emergency department. | 
| + | - | nl | Emerg Med J 22(4):275-6 (2005) |
| 36 | 2005 | Best evidence topic report: paddle position in emergency cardioversion of atrial fibrillation. | 
| + | - | nl | Emerg Med J 22(1):44-6 (2005) |
| 37 | 2004 | Best evidence topic report. Amiodarone or flecainide for cardioversion in acute onset atrial fibrillation. | 
| + | - | nl | Emerg Med J 21(2):199 (2004) |
| 38 | 2007 | Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis. | 
| + | - | nl | Heart 93(11):1433-40 (2007) |
| 39 | 2007 | Rhythm control and cardioversion. | 
| + | - | nl | Heart 93(1):29-34 (2007) |
| 40 | 2007 | Identification, diagnosis and assessment of atrial fibrillation. | 
| + | - | nl | Heart 93(1):25-8 (2007) |
| 41 | 2007 | Rate control in the medical management of atrial fibrillation. | 
| + | - | nl | Heart 93(1):35-8 (2007) |
| 42 | 2007 | Antithrombotic treatment in atrial fibrillation. | 
| + | - | nl | Heart 93(1):39-44 (2007) |
| 43 | 2007 | Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting. | 
| + | - | nl | Heart 93(1):45-7 (2007) |
| 44 | 2007 | Patient care pathway, implementation and audit criteria for patients with atrial fibrillation. | 
| + | - | nl | Heart 93(1):48-52 (2007) |
| 45 | 2006 | Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough? | 
| + | - | nl | Heart 92(9):1189-90 (2006) Betts TR |
| 46 | 2006 | Management of atrial fibrillation. | 
| + | - | nl | Heart 92(8):1177-82 (2006) |
| 47 | 2006 | Catheter and surgical ablation of atrial fibrillation. | 
| + | - | nl | Heart 92(2):266-74 (2006) |
| 48 | 2006 | Can we ablate permanent atrial fibrillation? | 
| + | - | nl | Heart 92(2):152-4 (2006) Haywood G |
| 49 | 2006 | Antithrombotic treatment in atrial fibrillation. | 
| + | - | nl | Heart 92(2):155-61 (2006) |
| 50 | 2005 | Atrial fibrillation ablation in the real world. | 
| + | - | nl | Heart 91(12):1507-8 (2005) |
| 51 | 2005 | Catheter ablation for atrial fibrillation. | 
| + | - | nl | Heart 91(1):7-9 (2005) |
| 52 | 2004 | Theory and practice of defibrillation: (1) Atrial fibrillation and DC conversion. | 
| + | - | nl | Heart 90(12):1493-8 (2004) |
| 53 | 2004 | Importance of using biphasic shock waveforms for cardioversion from atrial fibrillation: an unresolved issue. | 
| + | - | nl | Heart 90(10):1105-6 (2004) |
| 54 | 2004 | Role of oral anticoagulation in management of atrial fibrillation. | 
| + | - | nl | Heart 90(7):813-7 (2004) |
| 55 | 2003 | The role of echocardiography in atrial fibrillation and cardioversion. | 
| + | - | nl | Heart 89(12):1447-54 (2003) |
| 56 | 2003 | Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. | 
| + | - | nl | Heart 89(8):939-43 (2003) |
| 57 | 2003 | Pacing for atrial fibrillation. | 
| + | - | nl | Heart 89(1):106-12 (2003) |
| 58 | 2002 | Treatment of atrial fibrillation. | 
| + | - | nl | Heart 88(4):432-7 (2002) |
| 59 | 2002 | The right atrium as an anatomic set-up for re-entry: electrophysiology goes back to anatomy. | 
| + | - | nl | Heart 88(4):325-7 (2002) |
| 60 | 2002 | Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. | 
| + | - | nl | Heart 87(6):535-43 (2002) |
| 61 | 2002 | Current perspectives on curative catheter ablation of atrial fibrillation. | 
| + | - | nl | Heart 87(1):6-8 (2002) |
| 62 | 2001 | Radiofrequency catheter ablation of supraventricular arrhythmias. | 
| + | - | nl | Heart 85(5):594-600 (2001) |
| 63 | 1998 | Atrial fibrillation: towards an understanding of initiation, perpetuation, and specific treatment. | 
| + | - | nl | Heart 80(6):533-4 (1998) |
| 64 | 1998 | Ablate and pace: a pragmatic approach to paroxysmal atrial fibrillation not controlled by antiarrhythmic drugs. | 
| + | - | nl | Heart 79(6):531-3 (1998) |
| 65 | 1997 | Heart failure and atrial fibrillation: current concepts and controversies. | 
| + | - | nl | Heart 77(4):309-13 (1997) |
| 66 | 1994 | Surgery for atrial fibrillation. | 
| + | - | nl | Br Heart J 71(6):501-3 (1994) |
| 67 | 1993 | Antiarrhythmic drugs in the management of atrial fibrillation. | 
| + | - | nl | Br Heart J 70(4):304-6 (1993) |
| 68 | 1986 | The pulse in atrial fibrillation. | 
| + | - | nl | Br Heart J 56(1):1-3 (1986) |
| 69 | 2004 | Radiofrequency ablation for atrial fibrillation: different approaches. | 
| + | - | nl | Asian Cardiovasc Thorac Ann 12(3):272-7 (2004) |
| 70 | 2003 | Pharmacotherapy of atrial fibrillation. | 
| + | - | nl | Asian Cardiovasc Thorac Ann 11(4):364-74 (2003) |
| 71 | 2010 | Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? | 
| + | - | nl | Interact Cardiovasc Thorac Surg 10(2):306-11 (2010) |
| 72 | 2009 | Atrial fibrillation and acute decompensated heart failure. | 
| + | - | nl | Circ Heart Fail 2(1):72-3 (2009) |
| 73 | 2009 | Managing patients with rapid atrial fibrillation and decompensated heart failure. | 
| + | - | nl | Circ Heart Fail 2(1):71 (2009) |
| 74 | 1998 | Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion? | 
| + | - | nl | Can J Cardiol 14(10):1267-73 (1998) |
| 75 | 1998 | Atrial fibrillation: overview of therapeutic trials. | 
| + | - | nl | Can J Cardiol 14(10):1241-54 (1998) |
| 76 | 1997 | Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review. | 
| + | - | nl | Can J Cardiol 13(9):839-42 (1997) |
| 77 | 2007 | A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation. | 
| + | - | nl | Cardiovasc Drug Rev 25(4):342-56 (2007) |
| 78 | 2009 | Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation. | 
| + | - | nl | Exp Clin Cardiol 14(1):e1-7 (2009) |
| 79 | 2010 | Atrial fibrillation and dabigatran: has the time come to use new anticoagulants? | 
| + | - | nl | Cardiovasc Ther 28(5):295-301 (2010) Escobar C |
| 80 | 2010 | New antithrombotics for atrial fibrillation. | 
| + | - | nl | Cardiovasc Ther 28(5):278-86 (2010) Bereznicki LR |
| 81 | 2010 | Nonpharmacological therapies for atrial fibrillation. | 
| + | - | nl | Cardiovasc Ther 28(5):264-77 (2010) |
| 82 | 2010 | Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials. | 
| + | - | nl | Cardiovasc Ther 28(5):311-26 (2010) |
| 83 | 2010 | New approaches to atrial fibrillation management: treat the patient, not the ECG. | 
| + | - | nl | Cardiovasc Ther 28(5):302-10 (2010) |
| 84 | 2009 | Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry. | 
| + | - | nl | Cardiovasc Ther 27(4):230-8 (2009) Hammerstingl C |
| 85 | 2010 | Risk factors for atrial fibrillation: Not always severe heart disease, not always so 'lonely'. | 
| + | - | nl | Cardiol J 17(5):437-42 (2010) |
| 86 | 2009 | Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation. | 
| + | - | nl | Cardiol J 16(6):491-2 (2009) |
| 87 | 2009 | Catheter ablation of atrial fibrillation in the elderly: where do we stand? | 
| + | - | nl | Cardiol J 16(2):113-20 (2009) |
| 88 | 2009 | Cardiac resynchronization therapy and atrial fibrillation. | 
| + | - | nl | Cardiol J 16(1):4-10 (2009) |
| 89 | 2008 | Atrial conduction and atrial fibrillation: what can we learn from surface ECG? | 
| + | - | nl | Cardiol J 15(5):402-7 (2008) |
| 90 | 2008 | Non-invasive assessment of atrial electrophysiology: a vital part of the medical work-up in the setting of atrial arrhythmia. | 
| + | - | nl | Cardiol J 15(2):97-9 (2008) |
| 91 | 2008 | Surgical atrial fibrillation ablation: a review of contemporary techniques and energy sources. | 
| + | - | nl | Cardiol J 15(1):87-94 (2008) |
| 92 | 2009 | Is there a role for digoxin in atrial fibrillation without heart failure? | 
| + | - | nl | Cardiol J 16(5):483-6 (2009) |
| 93 | 2009 | Advances in atrial fibrillation ablation. | 
| + | - | nl | J Invasive Cardiol 21(5):247-54 (2009) |
| 94 | 2009 | Chronicling the evolution of catheter ablation for atrial fibrillation and ventricular tachycardia. | 
| + | - | nl | J Invasive Cardiol 21(5):239-43 (2009) |
| 95 | 2008 | Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation. | 
| + | - | nl | J Invasive Cardiol 20(4):E109-13 (2008) |
| 96 | 2004 | Right atrial ablation in the management of atrial fibrillation: point of view. | 
| + | - | nl | J Invasive Cardiol 16(9):489-92 (2004) |
| 97 | 2005 | Meta-analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation. | 
| + | - | nl | Eur J Cardiothorac Surg 28(5):724-30 (2005) |
| 98 | 2005 | Surgical treatment of atrial fibrillation; a systematic review. | 
| + | - | nl | Eur J Cardiothorac Surg 27(2):258-65 (2005) |
| 99 | 2008 | Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. | 
| + | - | nl | Europace 10(6):647-65 (2008) |
| 100 | 2008 | New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. | 
| + | - | nl | Europace 10(6):668-73 (2008) |
| 101 | 2008 | Novel non-pharmacological approaches for antiarrhythmic therapy of atrial fibrillation. | 
| + | - | nl | Europace 10(4):433-7 (2008) |
| 102 | 2007 | Interatrial conduction in the mechanisms of atrial fibrillation: from anatomy to cardiac signals and new treatment modalities. | 
| + | - | nl | Europace 9 Suppl 6(-):vi10-6 (2007) |
| 103 | 2007 | HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. | 
| + | - | nl | Europace 9(6):335-79 (2007) |
| 104 | 2006 | Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications. | 
| + | - | nl | Europace 8(11):911-26 (2006) |
| 105 | 2006 | The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. | 
| + | - | nl | Europace 8(11):943-9 (2006) |
| 106 | 2006 | ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. | 
| + | - | nl | Europace 8(9):651-745 (2006) |
| 107 | 2005 | Anticoagulation in atrial fibrillation and flutter. | 
| + | - | nl | Europace 7(5):492-9 (2005) |
| 108 | 2004 | Contributions of permanent cardiac pacing in the treatment of atrial fibrillation. | 
| + | - | nl | Europace 5 Suppl 1(-):S36-41 (2004) |
| 109 | 2004 | Treatment of atrial fibrillation by catheter-based procedures. | 
| + | - | nl | Europace 5 Suppl 1(-):S30-5 (2004) |
| 110 | 2004 | Surgical treatment of atrial fibrillation: a review. | 
| + | - | nl | Europace 5 Suppl 1(-):S20-9 (2004) |
| 111 | 2004 | Atrial fibrillation and heart failure: natural history and pharmacological treatment. | 
| + | - | nl | Europace 5 Suppl 1(-):S5-19 (2004) |
| 112 | 2003 | International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. | 
| + | - | nl | Europace 5(2):119-22 (2003) |
| 113 | 2009 | The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation. | 
| + | - | nl | Indian Pacing Electrophysiol J 9(5):260-7 (2009) |
| 114 | 2006 | Minimally invasive mapping guided surgical treatment of atrial fibrillation. Utopia or near future? | 
| + | - | nl | Indian Pacing Electrophysiol J 6(4):234-41 (2006) |
| 115 | 2005 | Rate-control or rhythm-control: where do we stand? | 
| + | - | nl | Indian Pacing Electrophysiol J 5(4):296-304 (2005) |
| 116 | 2005 | The role of biphasic shocks for transthoracic cardioversion of atrial fibrillation. | 
| + | - | nl | Indian Pacing Electrophysiol J 5(4):289-95 (2005) |
| 117 | 2004 | Evolution of curative therapies for atrial fibrillation review. | 
| + | - | nl | Indian Pacing Electrophysiol J 4(1):10-25 (2004) |
| 118 | 2008 | Evolving strategies in catheter ablation of long-standing atrial fibrillation. | 
| + | - | nl | Circ Arrhythm Electrophysiol 1(5):324-6 (2008) |
| 119 | 2008 | Further insight into the technique and outcomes of "curative" catheter ablation of atrial fibrillation. | 
| + | - | nl | Circ Arrhythm Electrophysiol 1(4):238-9 (2008) |
| 120 | 2008 | Atrial remodeling and atrial fibrillation: mechanisms and implications. | 
| + | - | nl | Circ Arrhythm Electrophysiol 1(1):62-73 (2008) |
| 121 | 2008 | The substrate maintaining persistent atrial fibrillation. | 
| + | - | nl | Circ Arrhythm Electrophysiol 1(1):2-5 (2008) |
| 122 | 2009 | Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. | 
| + | - | nl | Eur J Echocardiogr 10(3):383-8 (2009) |
| 123 | 2008 | What to do with an atrial thrombus? | 
| + | - | nl | Eur J Echocardiogr 9(1):204-5 (2008) |
| 124 | 2010 | Modern role for clopidogrel in management of atrial fibrillation and stroke reduction. | 
| + | - | nl | Vasc Health Risk Manag 6(-):95-103 (2010) |
| 125 | 2009 | Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation. | 
| + | - | nl | Vasc Health Risk Manag 5(-):783-91 (2009) |
| 126 | 2009 | Dronedarone for atrial fibrillation: a new therapeutic agent. | 
| + | - | nl | Vasc Health Risk Manag 5(-):635-42 (2009) |
| 127 | 2009 | Pleiotropic effects of statins in atrial fibrillation patients: the evidence. | 
| + | - | nl | Vasc Health Risk Manag 5(3):533-51 (2009) |
| 128 | 2007 | Management of atrial fibrillation. | 
| + | - | nl | Vasc Health Risk Manag 3(1):109-16 (2007) |
| 129 | 2008 | Heat shock proteins as molecular targets for intervention in atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 78(3):422-8 (2008) |
| 130 | 2005 | Genetic aspects of atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 67(3):414-8 (2005) |
| 131 | 2004 | Identifying and understanding the role of pulmonary vein activity in atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 64(3):387-94 (2004) |
| 132 | 2003 | New strategies in the surgical treatment of atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 58(3):501-9 (2003) |
| 133 | 2002 | Ablation therapy for atrial fibrillation (AF): past, present and future. | 
| + | - | nl | Cardiovasc Res 54(2):337-46 (2002) |
| 134 | 2002 | Molecular mechanisms of remodeling in human atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 54(2):315-24 (2002) |
| 135 | 2002 | Electrophysiological properties of the human atrium in atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 54(2):302-14 (2002) |
| 136 | 2002 | Thoracic veins and the mechanisms of non-paroxysmal atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 54(2):295-301 (2002) |
| 137 | 2002 | Basic and clinical electrophysiology of pulmonary vein ectopy. | 
| + | - | nl | Cardiovasc Res 54(2):287-94 (2002) |
| 138 | 2002 | Transgenic and knockout mouse models of atrial arrhythmias. | 
| + | - | nl | Cardiovasc Res 54(2):280-6 (2002) |
| 139 | 2002 | Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets. | 
| + | - | nl | Cardiovasc Res 54(2):270-9 (2002) |
| 140 | 2002 | Cellular electrophysiology of atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 54(2):259-69 (2002) |
| 141 | 2002 | Signal transduction systems and atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 54(2):247-58 (2002) |
| 142 | 2002 | Electrical, contractile and structural remodeling during atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 54(2):230-46 (2002) |
| 143 | 2002 | Mechanisms of atrial flutter and atrial fibrillation: distinct entities or two sides of a coin? | 
| + | - | nl | Cardiovasc Res 54(2):217-29 (2002) |
| 144 | 2002 | Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 54(2):204-16 (2002) |
| 145 | 2002 | Spotlight on atrial fibrillation-the 'complete arrhythmia'. | 
| + | - | nl | Cardiovasc Res 54(2):197-203 (2002) |
| 146 | 2001 | Establishing the link between a specific pathology and atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 52(2):169-70 (2001) |
| 147 | 2001 | Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. | 
| + | - | nl | Cardiovasc Res 52(1):14-24 (2001) |
| 148 | 1999 | Rate control in atrial fibrillation: role of atrial inputs to the AV node. | 
| + | - | nl | Cardiovasc Res 44(2):249-51 (1999) |
| 149 | 1999 | Atrial fibrillation-induced electrical remodeling in humans: what is the next step? | 
| + | - | nl | Cardiovasc Res 44(1):10-2 (1999) |
| 150 | 1999 | Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 42(2):298-308 (1999) |
| 151 | 2008 | The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS. | 
| + | - | nl | Br J Clin Pharmacol 66(3):345-51 (2008) |
| 152 | 2009 | Pharmacologic management of atrial fibrillation: established and emerging options. | 
| + | - | nl | J Manag Care Pharm 15(6 Suppl B):S10-8 (2009) |
| 153 | 2007 | The use of antithrombotics in patients presenting with stroke and atrial fibrillation. | 
| + | - | nl | Ther Clin Risk Manag 3(3):491-8 (2007) |
| 154 | 2008 | Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 12(34):iii-iv, xi-xiii, 1-198 (2008) |
| 155 | 2006 | A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. | 
| + | - | nl | Ann Surg 244(4):583-92 (2006) |
| 156 | 2008 | [Anticoagulation in atrial fibrillation]. | 
| + | - | nl | Hamostaseologie 28(4):213-6 (2008) |
| 157 | 2008 | The endothelium and atrial fibrillation. The prothrombotic state revisited. | 
| + | - | nl | Hamostaseologie 28(4):207-12 (2008) |
| 158 | 2008 | Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice. | 
| + | - | nl | J Thromb Haemost 6(10):1622-4 (2008) |
| 159 | 2008 | Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? | 
| + | - | nl | J Thromb Haemost 6(9):1500-6 (2008) |
| 160 | 2006 | Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review. | 
| + | - | nl | J Thromb Haemost 4(6):1180-5 (2006) |
| 161 | 2005 | Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. | 
| + | - | nl | J Thromb Haemost 3(6):1218-23 (2005) |
| 162 | 2004 | Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation. | 
| + | - | nl | Am J Manag Care 10(3 Suppl):S72-82 (2004) |
| 163 | 2004 | Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice. | 
| + | - | nl | Am J Manag Care 10(3 Suppl):S58-65 (2004) |
| 164 | 2004 | Epidemiology and management of new-onset atrial fibrillation. | 
| + | - | nl | Am J Manag Care 10(3 Suppl):S50-7 (2004) |
| 165 | 2005 | Chessboard of atrial fibrillation: reentry or focus? Single or multiple source(s)? Neurogenic or myogenic? | 
| + | - | nl | Am J Physiol Heart Circ Physiol 289(3):H977-9 (2005) Efimov IR |
| 166 | 2008 | In the clinic. Atrial fibrillation. | 
| + | - | nl | Ann Intern Med 149(9):ITC5-1-15; quiz ITC5-16 (2008) |
| 167 | 2007 | Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. | 
| + | - | nl | Ann Intern Med 146(12):857-67 (2007) |
| 168 | 2003 | Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. | 
| + | - | nl | Ann Intern Med 139(12):1018-33 (2003) |
| 169 | 2003 | Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. | 
| + | - | nl | Ann Intern Med 139(12):1009-17 (2003) |
| 170 | 2003 | Lessons from the Stroke Prevention in Atrial Fibrillation trials. | 
| + | - | nl | Ann Intern Med 138(10):831-8 (2003) |
| 171 | 1999 | Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. | 
| + | - | nl | Ann Intern Med 131(9):688-95 (1999) |
| 172 | 1999 | Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. | 
| + | - | nl | Ann Intern Med 131(7):492-501 (1999) |
| 173 | 1997 | Management of atrial fibrillation: simplicity surrounded by controversy. | 
| + | - | nl | Ann Intern Med 126(3):244-6 (1997) Prystowsky EN |
| 174 | 1996 | Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. | 
| + | - | nl | Ann Intern Med 125(4):311-23 (1996) |
| 175 | 1994 | Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. | 
| + | - | nl | Ann Intern Med 120(6):449-57 (1994) |
| 176 | 2005 | Surgical ablation of atrial fibrillation. | 
| + | - | nl | Ann Thorac Cardiovasc Surg 11(5):285-7 (2005) |
| 177 | 2005 | Surgery for atrial fibrillation. | 
| + | - | nl | Ann Thorac Cardiovasc Surg 11(3):154-8 (2005) |
| 178 | 1999 | When should heparin be given to patients with atrial fibrillation-related embolic brain infarcts? | 
| + | - | nl | Arch Neurol 56(9):1059-60 (1999) |
| 179 | 2008 | Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | 
| + | - | nl | Chest 133(6 Suppl):546S-592S (2008) |
| 180 | 2006 | Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema. | 
| + | - | nl | Chest 130(5):1296-9 (2006) |
| 181 | 2005 | The pathology of lone atrial fibrillation. | 
| + | - | nl | Chest 127(2):424-5 (2005) |
| 182 | 2004 | Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. | 
| + | - | nl | Chest 126(6):1938-45 (2004) |
| 183 | 2000 | Medical cardioversion of atrial fibrillation. | 
| + | - | nl | Chest 117(6):1529-31 (2000) |
| 184 | 1987 | Transesophageal pacing in atrial flutter. | 
| + | - | nl | Chest 92(1):4-5 (1987) |
| 185 | 2009 | Does bepridil create a paradigm shift in the treatment of persistent atrial fibrillation? | 
| + | - | nl | Circ J 73(6):1008-9 (2009) |
| 186 | 2009 | How useful is the 3-dimensional image for catheter ablation of atrial fibrillation? | 
| + | - | nl | Circ J 73(3):436-7 (2009) |
| 187 | 2003 | Treatment of paroxysmal atrial fibrillation by pulmonary vein isolation. | 
| + | - | nl | Circ J 67(7):567-71 (2003) |
| 188 | 2007 | Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation. | 
| + | - | nl | Circ Res 101(8):743-5 (2007) Spach MS |
| 189 | 2000 | Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. | 
| + | - | nl | Circ Res 87(6):440-7 (2000) |
| 190 | 2009 | Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. | 
| + | - | nl | Circulation 119(4):606-18 (2009) |
| 191 | 2008 | Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. | 
| + | - | nl | Circulation 118(12):1285-93 (2008) |
| 192 | 2007 | Atrial fibrillation-atrial flutter interactions: clinical implications for ablation. | 
| + | - | nl | Circulation 116(24):2774-5 (2007) Waldo AL |
| 193 | 2007 | Genes and atrial fibrillation: a new look at an old problem. | 
| + | - | nl | Circulation 116(7):782-92 (2007) |
| 194 | 2006 | ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. | 
| + | - | nl | Circulation 114(7):e257-354 (2006) |
| 195 | 2005 | Comparing different strategies for catheter ablation of atrial fibrillation. | 
| + | - | nl | Circulation 111(22):2866-8 (2005) Callans DJ |
| 196 | 2004 | ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). | 
| + | - | nl | Circulation 109(25):3223-43 (2004) |
| 197 | 2001 | ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. | 
| + | - | nl | Circulation 104(17):2118-50 (2001) |
| 198 | 2001 | Nonpharmacological approaches to atrial fibrillation. | 
| + | - | nl | Circulation 103(16):2120-5 (2001) |
| 199 | 2001 | Pathophysiology and prevention of atrial fibrillation. | 
| + | - | nl | Circulation 103(5):769-77 (2001) |
| 200 | 1998 | New approaches to the management of atrial fibrillation. The role of the atrial defibrillator. | 
| + | - | nl | Circulation 98(16):1594-6 (1998) |
| 201 | 1998 | Low-energy atrial defibrillation: a promising new technique. | 
| + | - | nl | Circulation 98(9):833-4 (1998) |
| 202 | 1996 | Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. | 
| + | - | nl | Circulation 93(6):1262-77 (1996) |
| 203 | 2008 | Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy. | 
| + | - | nl | Eur Heart J 29(7):840-2 (2008) Stramba-Badiale M |
| 204 | 2008 | Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? | 
| + | - | nl | Eur Heart J 29(7):915-22 (2008) |
| 205 | 2008 | Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. | 
| + | - | nl | Eur Heart J 29(5):632-9 (2008) |
| 206 | 2008 | New oral anticoagulants in atrial fibrillation. | 
| + | - | nl | Eur Heart J 29(2):155-65 (2008) |
| 207 | 2007 | From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation. | 
| + | - | nl | Eur Heart J 28(23):2827-9 (2007) |
| 208 | 2007 | Outcome parameters for trials in atrial fibrillation: executive summary. | 
| + | - | nl | Eur Heart J 28(22):2803-17 (2007) |
| 209 | 2007 | Management of atrial fibrillation in patients with heart failure. | 
| + | - | nl | Eur Heart J 28(21):2568-77 (2007) |
| 210 | 2007 | Stroke prevention in atrial fibrillation: antiplatelet therapy revisited. | 
| + | - | nl | Eur Heart J 28(8):926-8 (2007) Lip GY |
| 211 | 2007 | Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. | 
| + | - | nl | Eur Heart J 28(4):457-62 (2007) |
| 212 | 2006 | ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). | 
| + | - | nl | Eur Heart J 27(16):1979-2030 (2006) |
| 213 | 2006 | Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). | 
| + | - | nl | Eur Heart J 27(16):1954-64 (2006) |
| 214 | 2006 | Anticoagulation for stroke prevention in atrial fibrillation: is gender important? | 
| + | - | nl | Eur Heart J 27(16):1893-4 (2006) Lip GY |
| 215 | 2006 | Is atrial fibrillation an inflammatory disorder? | 
| + | - | nl | Eur Heart J 27(2):136-49 (2006) |
| 216 | 2005 | Inflammation in the genesis and perpetuation of atrial fibrillation. | 
| + | - | nl | Eur Heart J 26(20):2083-92 (2005) |
| 217 | 2005 | Pulmonary vein stenosis: still the Achilles heel of ablation for atrial fibrillation? | 
| + | - | nl | Eur Heart J 26(14):1355-7 (2005) Purerfellner H |
| 218 | 2005 | Towards more effective techniques for catheter ablation of atrial fibrillation: to aim for electrical disconnection of pulmonary veins or not? | 
| + | - | nl | Eur Heart J 26(7):627-30 (2005) Cappato R |
| 219 | 2004 | Pharmacological cardioversion of recent onset atrial fibrillation. | 
| + | - | nl | Eur Heart J 25(15):1274-6 (2004) |
| 220 | 2003 | Quality of life in nonpharmacologic treatment of atrial fibrillation. | 
| + | - | nl | Eur Heart J 24(15):1387-400 (2003) |
| 221 | 2001 | Transoesophageal echocardiography for immediate and safe cardioversion in patients with atrial fibrillation. | 
| + | - | nl | Eur Heart J 22(22):2041-4 (2001) |
| 222 | 2001 | ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. | 
| + | - | nl | Eur Heart J 22(20):1852-923 (2001) |
| 223 | 2001 | Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF). | 
| + | - | nl | Eur Heart J 22(10):801-2 (2001) |
| 224 | 2000 | The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem. | 
| + | - | nl | Eur Heart J 21(10):795-8 (2000) |
| 225 | 2000 | Systematic review of the management of atrial fibrillation in patients with heart failure. | 
| + | - | nl | Eur Heart J 21(8):614-32 (2000) |
| 226 | 2000 | Cardioversion of chronic atrial fibrillation-towards a more aggressive approach. | 
| + | - | nl | Eur Heart J 21(4):263 (2000) |
| 227 | 2000 | Chronic atrial fibrillation-how to best reach a permanent sinus rhythm? | 
| + | - | nl | Eur Heart J 21(1):11-2 (2000) |
| 228 | 1998 | Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. | 
| + | - | nl | Eur Heart J 19(9):1294-320 (1998) |
| 229 | 1998 | Anticoagulation for cardioversion of atrial arrhythmias. | 
| + | - | nl | Eur Heart J 19(4):548-52 (1998) |
| 230 | 1997 | Intravenous digoxin: still the drug of choice for acute termination of atrial fibrillation? | 
| + | - | nl | Eur Heart J 18(4):546-7 (1997) |
| 231 | 1996 | Unravelling the electrical mysteries of atrial fibrillation. | 
| + | - | nl | Eur Heart J 17 Suppl C(-):2-9 (1996) |
| 232 | 2007 | The new NICE guideline on atrial fibrillation management. | 
| + | - | nl | Heart 93(1):23 (2007) |
| 233 | 1998 | Problems in the pharmacological evaluation of paroxysmal atrial fibrillation. | 
| + | - | nl | Intern Med 37(12):997-8 (1998) |
| 234 | 2003 | Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? | 
| + | - | nl | JAMA 290(20):2685-92 (2003) |
| 235 | 2001 | Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. | 
| + | - | nl | JAMA 285(22):2864-70 (2001) |
| 236 | 1999 | Preventing stroke in patients with atrial fibrillation. | 
| + | - | nl | JAMA 281(19):1830-5 (1999) |
| 237 | 2009 | Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. | 
| + | - | nl | Mayo Clin Proc 84(7):643-62 (2009) |
| 238 | 2004 | The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. | 
| + | - | nl | Mayo Clin Proc 79(7):904-13 (2004) |
| 239 | 2002 | Direct current cardioversion of atrial fibrillation--the next 40 years. | 
| + | - | nl | Mayo Clin Proc 77(9):895-6 (2002) |
| 240 | 2000 | Atrial fibrillation in dialysis patients. | 
| + | - | nl | Nephrol Dial Transplant 15(6):765-8 (2000) |
| 241 | 2003 | Emergency management of atrial fibrillation. | 
| + | - | nl | Postgrad Med J 79(932):313-9 (2003) |
| 242 | 2003 | Present treatment options for atrial fibrillation. | 
| + | - | nl | Postgrad Med J 79(928):67-73 (2003) |
| 243 | 1995 | Cardioversion of atrial fibrillation. | 
| + | - | nl | Postgrad Med J 71(838):457-65 (1995) |
| 244 | 2009 | Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. | 
| + | - | nl | Stroke 40(1):235-40 (2009) Gladstone DJ |
| 245 | 2008 | Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. | 
| + | - | nl | Stroke 39(1):227-30 (2008) Gattellari M |
| 246 | 2007 | Predicting stroke risk in patients with atrial fibrillation. | 
| + | - | nl | Stroke 38(9):2409 (2007) Hackam DG |
| 247 | 2007 | Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. | 
| + | - | nl | Stroke 38(2 Suppl):624-30 (2007) |
| 248 | 2007 | Advances in surgical treatment of atrial fibrillation. | 
| + | - | nl | Stroke 38(2 Suppl):618-23 (2007) |
| 249 | 2007 | Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control. | 
| + | - | nl | Stroke 38(2 Suppl):615-7 (2007) |
| 250 | 2001 | Atrial fibrillation and stroke : concepts and controversies. | 
| + | - | nl | Stroke 32(3):803-8 (2001) |
| 251 | 2000 | Underuse of antithrombotic therapy in stroke patients with chronic atrial fibrillation. | 
| + | - | nl | Stroke 31(9):2266-7 (2000) |
| 252 | 1997 | Warfarin use among patients with atrial fibrillation. | 
| + | - | nl | Stroke 28(12):2382-9 (1997) |
| 253 | 1997 | Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke. | 
| + | - | nl | Stroke 28(2):311-5 (1997) |
| 254 | 1990 | Thromboembolic complications in atrial fibrillation. | 
| + | - | nl | Stroke 21(1):4-13 (1990) |
| 255 | 1988 | Atrial fibrillation and stroke: new ideas, persisting dilemmas. | 
| + | - | nl | Stroke 19(8):937-41 (1988) |
| 256 | 2009 | Mapping of atrial fibrillation--basic research and clinical applications. | 
| + | - | nl | Swiss Med Wkly 139(35-36):496-504 (2009) |
| 257 | 2006 | Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines. | 
| + | - | nl | Swiss Med Wkly 136(47-48):757-60 (2006) |
| 258 | 2000 | Atrial fibrillation: the most common arrhythmia. | 
| + | - | nl | Tex Heart Inst J 27(3):257-67 (2000) |
| 259 | 1999 | Low-energy internal cardioversion of atrial fibrillation after failed external cardioversion: Texas Heart Institute experience and review of the literature. | 
| + | - | nl | Tex Heart Inst J 26(2):114-9 (1999) |
| 260 | 1995 | Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice. | 
| + | - | nl | West J Med 163(2):145-52 (1995) |
| 261 | 1995 | Treatment of nonvalvular atrial fibrillation. | 
| + | - | nl | West J Med 162(4):331-9 (1995) |
| 262 | 1989 | Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation. | 
| + | - | nl | West J Med 151(2):172-9 (1989) |
| 263 | 1991 | Familial congenital brachial palsy. | 
| + | - | nl | Am J Med Genet 41(3):322-4 (1991) |
| 264 | 2008 | Mystery of biphasic defibrillation waveform efficacy is it calcium? | 
| + | - | nl | J Am Coll Cardiol 52(10):836-8 (2008) Daubert JP |
| 265 | 2008 | Molecular genetics of atrial fibrillation. | 
| + | - | nl | J Am Coll Cardiol 52(4):241-50 (2008) |
| 266 | 2008 | Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. | 
| + | - | nl | J Am Coll Cardiol 51(8):828-35 (2008) |
| 267 | 2008 | Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. | 
| + | - | nl | J Am Coll Cardiol 51(8):802-9 (2008) |
| 268 | 2008 | Atrial-selective approaches for the treatment of atrial fibrillation. | 
| + | - | nl | J Am Coll Cardiol 51(8):787-92 (2008) |
| 269 | 2008 | Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. | 
| + | - | nl | J Am Coll Cardiol 51(1):1-11 (2008) |
| 270 | 2007 | Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. | 
| + | - | nl | J Am Coll Cardiol 50(21):2021-8 (2007) |
| 271 | 2007 | Is pulmonary vein antrum isolation a critical determinant of recurrent arrhythmias after ablation of atrial fibrillation? | 
| + | - | nl | J Am Coll Cardiol 50(9):875-6 (2007) Lindsay BD |
| 272 | 2006 | Cardiovascular imaging in the management of atrial fibrillation. | 
| + | - | nl | J Am Coll Cardiol 48(10):2077-84 (2006) |
| 273 | 2006 | ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). | 
| + | - | nl | J Am Coll Cardiol 48(4):854-906 (2006) |
| 274 | 2005 | Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. | 
| + | - | nl | J Am Coll Cardiol 45(11):1832-9 (2005) |
| 275 | 2004 | Drug-induced atrial fibrillation. | 
| + | - | nl | J Am Coll Cardiol 44(11):2117-24 (2004) |
| 276 | 2004 | ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation). | 
| + | - | nl | J Am Coll Cardiol 44(2):475-95 (2004) |
| 277 | 2003 | Obliteration of the left atrial appendage for prevention of thromboembolism. | 
| + | - | nl | J Am Coll Cardiol 42(7):1259-61 (2003) Halperin JL |
| 278 | 2003 | Restoring sinus rhythm in atrial fibrillation: a Pyrrhic victory? | 
| + | - | nl | J Am Coll Cardiol 42(1):30-2 (2003) Dorian P |
| 279 | 2003 | Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. | 
| + | - | nl | J Am Coll Cardiol 41(2):255-62 (2003) |
| 280 | 2002 | High intensity anticoagulation for cardioversion of atrial arrhythmias? The shocking truth. | 
| + | - | nl | J Am Coll Cardiol 40(5):934-6 (2002) |
| 281 | 2001 | Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter. | 
| + | - | nl | J Am Coll Cardiol 38(5):1498-504 (2001) |
| 282 | 2001 | ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. | 
| + | - | nl | J Am Coll Cardiol 38(4):1231-66 (2001) |
| 283 | 2001 | Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. | 
| + | - | nl | J Am Coll Cardiol 37(3):691-704 (2001) |
| 284 | 2001 | Epidemiology and natural history of atrial fibrillation: clinical implications. | 
| + | - | nl | J Am Coll Cardiol 37(2):371-8 (2001) |
| 285 | 1998 | Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. | 
| + | - | nl | J Am Coll Cardiol 32(1):275-82 (1998) |
| 286 | 2004 | MDCT of the left atrium and pulmonary veins in planning radiofrequency ablation for atrial fibrillation: a how-to guide. | 
| + | - | nl | AJR Am J Roentgenol 183(3):767-78 (2004) |
| 287 | 2003 | Multi-detector row CT of the left atrium and pulmonary veins before radio-frequency catheter ablation for atrial fibrillation. | 
| + | - | nl | Radiographics 23 Spec No(-):S35-48; discussion S48-50 (2003) |
| 288 | 2003 | Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging. | 
| + | - | nl | Radiographics 23 Spec No(-):S19-33; discussion S48-50 (2003) |
| 289 | 2004 | Atrial fibrillation. | 
| + | - | nl | CMAJ 171(7):755-60 (2004) |
| 290 | 2002 | New insights into the mechanisms and management of atrial fibrillation. | 
| + | - | nl | CMAJ 167(9):1012-20 (2002) |
| 291 | 1999 | Preventing stroke in atrial fibrillation: why are so many eligible patients not receiving anticoagulant therapy? | 
| + | - | nl | CMAJ 161(5):533-4 (1999) Connolly SJ |
| 292 | 1999 | Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice. | 
| + | - | nl | CMAJ 161(5):493-7 (1999) |
| 293 | 2011 | Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. | 
| + | - | nl | BMJ 342(-):d1250 (2011) |
| 294 | 2003 | Persistent atrial fibrillation: rate control or rhythm control. Rate control is not inferior to rhythm control. | 
| + | - | nl | BMJ 326(7404):1411-2 (2003) |
| 295 | 2007 | Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat. | 
| + | - | nl | BMJ 334(7594):637 (2007) |
| 296 | 2008 | Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation. | 
| + | - | nl | BMJ 336(7644):614-5 (2008) |
| 297 | 2008 | Catheter ablation for atrial fibrillation. | 
| + | - | nl | BMJ 336(7648):819-26 (2008) |
| 298 | 2011 | Managing newly diagnosed atrial fibrillation: rate, rhythm, and risk. | 
| + | - | nl | Cleve Clin J Med 78(4):258-64 (2011) |
| 299 | 2011 | Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review. | 
| + | - | nl | Mayo Clin Proc 86(6):509-21 (2011) |
| 300 | 2009 | Dilemmas in the management of atrial fibrillation in chronic kidney disease. | 
| + | - | nl | J Am Soc Nephrol 20(4):705-11 (2009) |
| 301 | 2004 | Atrial fibrillation: a perspective: thinking inside and outside the box. | 
| + | - | nl | Circulation 109(25):3089-95 (2004) |
| 302 | 2007 | Catheter ablation for atrial fibrillation. | 
| + | - | nl | Circulation 116(13):1515-23 (2007) |
| 303 | 2009 | Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. | 
| + | - | nl | Circulation 119(10):1363-9 (2009) |
| 304 | 2009 | Reducing stroke rates in patients with atrial fibrillation: how low can we go? | 
| + | - | nl | Circulation 120(13):1169-70 (2009) |
| 305 | 2009 | New therapies for stroke prevention in atrial fibrillation: the long road to enhanced efficacy. | 
| + | - | nl | Circulation 120(12):1024-6 (2009) |
| 306 | 2009 | Acute management of atrial fibrillation. | 
| + | - | nl | Chest 135(3):849-59 (2009) |
| 307 | 2009 | The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis? | 
| + | - | nl | Chest 136(4):1128-33 (2009) |
| 308 | 2005 | Atrial fibrillation: multi-detector row CT of pulmonary vein anatomy prior to radiofrequency catheter ablation--initial experience. | 
| + | - | nl | Radiology 234(3):702-9 (2005) |
| 309 | 2011 | Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents. | 
| + | - | nl | Circ J 75(7):1539-47 (2011) |
| 310 | 2010 | Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version. | 
| + | - | nl | Circ J 74(11):2479-500 (2010) |
| 311 | 2010 | The 2010 update of the ESC guidelines for the management of atrial fibrillation. Beyond the rate or rhythm strategy debate. | 
| + | - | nl | Circ J 74(12):2538-41 (2010) |
| 312 | 2010 | The 2010 update of the ESC guidelines for the management of atrial fibrillation. | 
| + | - | nl | Circ J 74(12):2534-7 (2010) |
| 313 | 2010 | Three-dimensional electroanatomic mapping systems in catheter ablation of atrial fibrillation. | 
| + | - | nl | Circ J 74(1):18-23 (2010) |
| 314 | 2007 | Thoracic vein arrhythmias. | 
| + | - | nl | Circ J 71 Suppl A(-):A20-5 (2007) |
| 315 | 2009 | The incidence of ischemic stroke. Paroxysmal Af vs persistent/permanent Af. | 
| + | - | nl | Circ J 73(8):1393-4 (2009) |
| 316 | 2008 | Holt-oram syndrome and atrial fibrillation: opening the (T)-box. | 
| + | - | nl | Circ Res 102(11):1304-6 (2008) Cerbai E |
| 317 | 2009 | The role of connexin40 in atrial fibrillation. | 
| + | - | nl | Cardiovasc Res 84(1):15-23 (2009) |
| 318 | 2010 | Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | 
| + | - | nl | Eur Heart J 31(19):2369-429 (2010) |
| 319 | 2010 | Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation. | 
| + | - | nl | Eur Heart J 31(5):542-51 (2010) |
| 320 | 2007 | D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism? | 
| + | - | nl | Eur Heart J 28(18):2179-80 (2007) Cohen A |
| 321 | 2009 | Atrial fibrillation complicating acute myocardial infarction: how should it be interpreted and how should it be treated and prevented? | 
| + | - | nl | Eur Heart J 30(9):1035-7 (2009) Cappato R |
| 322 | 2009 | Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. | 
| + | - | nl | Eur Heart J 30(9):1038-45 (2009) |
| 323 | 2010 | Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. | 
| + | - | nl | Eur Heart J 31(8):967-75 (2010) |
| 324 | 2010 | The evolving field of stroke prevention in patients with atrial fibrillation. | 
| + | - | nl | Stroke 41(10 Suppl):S17-20 (2010) |
| 325 | 2010 | Stroke risk and antithrombotic strategies in atrial fibrillation. | 
| + | - | nl | Stroke 41(11):2705-13 (2010) |
| 326 | 2007 | Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. | 
| + | - | nl | Stroke 38(11):2935-40 (2007) |
| 327 | 2008 | The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited. | 
| + | - | nl | Stroke 39(5):1406-8 (2008) |
| 328 | 2008 | Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. | 
| + | - | nl | Stroke 39(6):1901-10 (2008) |
| 329 | 2009 | Optimizing antiplatelet therapy in high-risk patients with atrial fibrillation: insights from Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE A). | 
| + | - | nl | Stroke 40(12):3883-5 (2009) |
| 330 | 2003 | Curative treatment of atrial fibrillation: which is the best technique? | 
| + | - | nl | Rev Port Cardiol 22(11):1311-4 (2003) de Sousa J |
| 331 | 2007 | Atrial fibrillation: from pathophysiology to ablation. | 
| + | - | nl | Rev Port Cardiol 26(7-8):707-12 (2007) Adragao P |
| 332 | 2009 | Ablation of atrial fibrillation: what is the gold standard strategy? | 
| + | - | nl | Rev Port Cardiol 28(10):1043-6 (2009) Oliveira M |
| 333 | 2011 | Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. | 
| + | - | nl | Europace 13(2):161-73 (2011) |
| 334 | 2010 | Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | 
| + | - | nl | Europace 12(10):1360-420 (2010) |
| 335 | 2010 | Genetics of lone atrial fibrillation. | 
| + | - | nl | Europace 12(10):1351-2 (2010) Koopmann TT |
| 336 | 2010 | Warfarin in haemodialysis patients with atrial fibrillation: what benefit? | 
| + | - | nl | Europace 12(12):1666-72 (2010) |
| 337 | 2010 | Surgical ablation of lone atrial fibrillation on the beating heart: the chaos continues. | 
| + | - | nl | Europace 12(3):297-8 (2010) |
| 338 | 2010 | Do non-antiarrhythmic drugs have enough pleiotropic power to reduce atrial fibrillation? | 
| + | - | nl | Europace 12(3):299-300 (2010) Folkeringa RJ |
| 339 | 2010 | Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. | 
| + | - | nl | Europace 12(6):761-3 (2010) Fauchier L |
| 340 | 2008 | Balloon cryoablation for paroxysmal atrial fibrillation. | 
| + | - | nl | Europace 10(11):1251-2 (2008) |
| 341 | 2008 | Imaging of pulmonary veins during catheter ablation for atrial fibrillation: the role of multi-slice computed tomography. | 
| + | - | nl | Europace 10 Suppl 3(-):iii14-21 (2008) |
| 342 | 2008 | Imaging in catheter ablation for atrial fibrillation: enhancing the clinician's view. | 
| + | - | nl | Europace 10 Suppl 3(-):iii2-7 (2008) |
| 343 | 2008 | Evaluating the left atrium by magnetic resonance imaging. | 
| + | - | nl | Europace 10 Suppl 3(-):iii22-7 (2008) |
| 344 | 2008 | Intracardiac echocardiography during catheter ablation of atrial fibrillation. | 
| + | - | nl | Europace 10 Suppl 3(-):iii42-7 (2008) |
| 345 | 2008 | Image integration in catheter ablation of atrial fibrillation. | 
| + | - | nl | Europace 10 Suppl 3(-):iii48-56 (2008) |
| 346 | 2008 | Managing catheter ablation for atrial fibrillation: the role of echocardiography. | 
| + | - | nl | Europace 10 Suppl 3(-):iii8-13 (2008) |
| 347 | 2010 | Pulmonary vein isolation with the pulmonary vein ablation catheter (PVAC): is there a price to pay for a 'simpler', shorter procedure? | 
| + | - | nl | Europace 12(4):455-7 (2010) |
| 348 | 2010 | Animal models for atrial fibrillation: clinical insights and scientific opportunities. | 
| + | - | nl | Europace 12(2):160-72 (2010) |
| 349 | 2010 | Termination of atrial fibrillation by flecainide: mechanistic insights from spectral analysis. | 
| + | - | nl | Europace 12(4):453-4 (2010) Hunter RJ |
| 350 | 2007 | Studying atrial fibrillation: what can we learn from the AFTherapy study? | 
| + | - | nl | Europace 9(12):1107-9 (2007) |
| 351 | 2007 | Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. | 
| + | - | nl | Europace 9(11):1006-23 (2007) |
| 352 | 2007 | Catheter ablation of atrial fibrillation: do we know what we are doing? | 
| + | - | nl | Europace 9(11):1002-5 (2007) |
| 353 | 2009 | Reflections on reconduction after pulmonary vein isolation. | 
| + | - | nl | Europace 11(4):400-1 (2009) Van Belle Y |
| 354 | 2009 | Comprehensive upstream treatment for atrial fibrillation, when and how? | 
| + | - | nl | Europace 11(4):397-9 (2009) Pisters R |
| 355 | 2008 | Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway. | 
| + | - | nl | Europace 10(3):294-302 (2008) |
| 356 | 2008 | Exploring the potential of pulmonary vein recordings: can they help elucidate mechanisms of paroxysmal atrial fibrillation? | 
| + | - | nl | Europace 10(6):690-1 (2008) |
| 357 | 2009 | Cardiac resynchronization therapy in heart failure patients with atrial fibrillation. | 
| + | - | nl | Europace 11 Suppl 5(-):v82-6 (2009) |
| 358 | 2009 | Electrophysiological evaluation of pulmonary vein isolation. | 
| + | - | nl | Europace 11(11):1423-33 (2009) |
| 359 | 2009 | Atrial antitachycardia pacing: do we still need to talk about it? | 
| + | - | nl | Europace 11(8):977-9 (2009) Janko S |
| 360 | 2009 | How safe is the antiarrhythmic drug therapy in atrial fibrillation? | 
| + | - | nl | Europace 11(7):837-9 (2009) Krishnamoorthy S |
| 361 | 2009 | The risk of antiarrhythmic drugs in atrial fibrillation: 20 years of controversies. | 
| + | - | nl | Europace 11(7):840-1 (2009) Le Heuzey JY |
| 362 | 2010 | Management of atrial fibrillation. | 
| + | - | nl | Discov Med 10(52):201-8 (2010) |
| 363 | 2011 | Recent advances in the molecular pathophysiology of atrial fibrillation. | 
| + | - | nl | J Clin Invest 121(8):2955-68 (2011) |
| 364 | 2003 | Atrial fibrillation: new horizons. | 
| + | - | nl | Chang Gung Med J 26(10):712-21 (2003) |
| 365 | 2008 | Surgical treatment of atrial fibrillation with concomitant mitral valve disease: an Asian review. | 
| + | - | nl | Chang Gung Med J 31(6):538-45 (2008) |
| 366 | 2010 | Lenient versus strict rate control in patients with atrial fibrillation. | 
| + | - | nl | N Engl J Med 362(15):1363-73 (2010) |
| 367 | 2010 | Dronedarone for the treatment of atrial fibrillation and atrial flutter. | 
| + | - | nl | Health Technol Assess 14(Suppl. 2):55-62 (2010) |
| 368 | 2005 | Thyrotoxic atrial fibrillation. | 
| + | - | nl | MedGenMed 7(1):74 (2005) |
| 369 | 2008 | Atrial fibrillation (chronic). | 
| + | - | nl | Clin Evid (Online) 2008(-):- (2008) |
| 370 | 2008 | Atrial fibrillation (acute onset). | 
| + | - | nl | Clin Evid (Online) 2008(-):- (2008) |
| 371 | 2008 | Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation. | 
| + | - | nl | Can J Cardiol 24(3):195-8 (2008) |
| 372 | 2008 | Transcatheter occlusion devices for the prevention of stroke in patients with atrial fibrillation. | 
| + | - | nl | Hellenic J Cardiol 49(1):33-6 (2008) |
| 373 | 2011 | Dronedarone for the management of atrial fibrillation. | 
| + | - | nl | Swiss Med Wkly 141(-):w13158 (2011) |
| 374 | 2010 | Cryoballoon ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. | 
| + | - | nl | Swiss Med Wkly 140(15-16):214-21 (2010) |
| 375 | 2010 | Use of the CHADS2 risk score to guide antithrombotic treatment in patients with atrial fibrillation--room for improvement. | 
| + | - | nl | Swiss Med Wkly 140(5-6):73-7 (2010) |
| 376 | 2011 | Learning what works in surgical cryoablation of atrial fibrillation: results of different application techniques and benefits of prospective follow-up. | 
| + | - | nl | Interact Cardiovasc Thorac Surg 13(5):480-4 (2011) |
| 377 | 2011 | The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. | 
| + | - | nl | Vasc Health Risk Manag 7(-):193-202 (2011) |
| 378 | 2003 | Prediction of atrial fibrillation from surface ECG: review of methods and algorithms. | 
| + | - | nl | Ann Ist Super Sanita 39(2):195-203 (2003) |
| 379 | 2011 | Impact of new criteria for anticoagulant treatment in atrial fibrillation. | 
| + | - | nl | Rev Esp Cardiol 64(8):649-53 (2011) |
| 380 | 2011 | The improved but unfinished business of stroke risk stratification in atrial fibrillation. | 
| + | - | nl | Rev Esp Cardiol 64(8):639-41 (2011) Banerjee A |
| 381 | 2009 | Atrial fibrillation ablation: how far have we come? | 
| + | - | nl | Rev Esp Cardiol 62(10):1087-91 (2009) |